Covishield should not be taken by people who are severely allergic to any of its ingredients: Serum Institute
The recipient information sheet on the major vaccine website is intended to help the recipient understand the risks and benefits of the Covishield vaccine.
People who are severely allergic to any ingredient in the COVID-19 “Covishield” vaccine are advised not to take it, the Serum Institute of India has said.
According to the information sheet for the vaccine recipient by the Serum Institute of India, one should not receive the Covishield vaccine if the person has had a severe allergic reaction after a previous dose of this vaccine.
The Covishield vaccine ingredients are “L-Histidine, L-Histidine Hydrochloride Monohydrate, Magnesium Chloride Hexahydrate, Polysorbate 80, Ethanol, Sucrose, Sodium Chloride, Disodium Edetate Dihydrate (EDTA), Water for Injection,” Serum said. Institute.
Read also: Covaxin not to be used in case of allergy, fever, poor immunity
The vaccine recipient information sheet on the Major Vaccine website is to help the recipient understand the risks and benefits of the Covishield vaccine.
The vaccine manufacturer also said that the vaccine recipient should also inform the health care provider of any medical conditions before receiving the Covishield vaccine, including “if you have ever had a severe allergic reaction (anaphylaxis) after a medication. , a food, a vaccine or any other ingredient of the Covishield vaccine “.
Recipients should also tell the healthcare professional if they have a fever, have a bleeding disorder or are taking a blood thinner, and also if they are immunocompromised or are taking any medicine that affects your immune system. he added.
Also read: Covaxin recipients invited to sign consent form on ‘clinical trial mode’
The information sheet also states that if a person is pregnant or plans to become pregnant or breastfeeding, they should tell the health care provider before taking the vaccine.
The vaccine recipient should also tell the health care provider if “you have received another COVID-19 vaccine,” the Serum Institute said.
According to the Union Health Ministry, a total of 3,81,305 beneficiaries had been vaccinated against COVID-19 in the country until 5 p.m. Monday and 580 adverse events following the vaccination were reported.